Summary Dermal fibroblasts cultured from members of a family presenting multiple polyps and sarcomas were compared with fibroblast strains from unrelated healthy donors for sensitivity to killing by four genotoxic agents. Cells from the sister of the male proband (strain 3437T), mother (strain 3703T), two of his paternal aunts (3701T and 3704T) and one paternal uncle (3702T) displayed marked resistance (1.8 to 4.3 times greater than the normal mean) to 4-nitroquinoline 1-oxide (4NQO), a procarcinogen whose DNAdamaging properties encompass those of both far (254 nm) ultraviolet (UV) light and ionising radiation. These same 4NQO-resistant cells, however, responded normally to reproductive inactivation by UV light, 'Co radiation or the alkylating agent methylnitrosourea, signifying that the abnormal resistance of these cells to 4NQO is not associated with aberrant DNA metabolism. In keeping with this conclusion, exposure to a given dose of 4NQO produced decreased amounts of DNA damage and stimulated lower levels of repair DNA synthesis in all five 4NQO-resistant strains than in normal controls. Moreover, exogenous radiolabelled 4NQO accumulated to a lesser extent in the 4NQO-resistant than in the normal fibroblasts. Cell sonicates of strains 3437T, 3701T and 3702T exhibited reduced capacities (40-60% of normal) to catalise the conversion of 4NQO to the proximate carcinogen 4-hydroxyaminoquinoline 1-oxide. However, the 4NQO-resistant strains 3703T and 3704T carried out 4NQO bioreduction at normal rates. Our data therefore indicate that enhanced resistance to 4NQO cytotoxicity in 3437T, 3701T and 3702T is a consequence of anomalies in both intracellular accumulation and enzymatic reduction of 4NQO, whereas 4NQO resistance in 3703T and 3704T appears to result solely from reduced intracellular drug accumulation.
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Some two decades ago it was demonstrated that cells from patients afflicted with xeroderma pigmentosum, an autosomal recessively transmitted, sunlight-sensitive, skin cancer disease, exhibit marked intolerance to the cytotoxic effects of ultraviolet (UV) light ascribable to malfunctional excision-repair of UV-induced DNA damage (Cleaver, 1968) . Since then, several other cancer-prone conditions characterised by cellular hypersensitivity to physical and chemical carcinogens and impaired DNA metabolism have been identified (Ramsay et al., 1982; Paterson & Smith, 1979; Paterson et al., 1984a,b; Lehmann et al., 1988; Mayne et al., 1988; Cleaver & Kraemer, 1989; Maher et al., 1990) . These findings implicated DNA injury from environmental genotoxins as a key causative factor in carcinogenesis and led to the notion that normal enzymatic processing of DNA damage plays a crucial role in affording protection from the development of the malignant state (Cleaver, 1989) . As a test of this hypothesis, cells derived from individuals with an assortment of cancerassociated diseases have been surveyed for their response to a panel of DNA-damaging agents (see, e.g., Arlett & Harcourt, 1980; Weichselbaum et al., 1980; Paterson et al., 1983; Deschavanne et al., 1986) . The overall aim of this line of investigation is to obtain new insight into the molecular mechanisms underlying the interaction between environmental agents and host susceptibility factors in predisposing humans to various forms of malignant disease.
We report here the outcome of our studies conducted on noncancerous dermal fibroblasts established from members of a family characterised by the presence of excessive colonic polyps prone to malignant transformation in coexistence with malignant extra-alimentary sarcomas (Fraumeni et al., 1968) .
The pattern of cancer development in the kinship is compatible with autosomal dominant inheritance of a single mutant, pleiotropic gene of high penetrance (see Figure 1 for an abridged family pedigree). Strains from five family members are shown here to exhibit abnormal resistance to killing by the potent carcinogen 4-nitroquinoline 1-oxide (4NQO), but to respond normally to 60Co radiation and the alkylating agent methylnitrosourea (MNU). In addition, 4NQO-resistant strains from two affected family members examined display normal sensitivity to 254 nm UV light.
4NQO is itself biologically inert until enzymatically converted to an ultimate carcinogenic metabolite. The first step in 4NQO bioreduction entails the conversion of the parent compound to 4-hydroxyaminoquinoline 1-oxide (4HAQO) (Sugimura et al., 1966; Tsuda et al., 1984) . Several cellular reductases are capable of mediating this reaction, including DT-diaphorase [NAD(H):(quinone-acceptor) oxidoreductase (EC 1.6.99.2)] (Tsuda et al., 1984) , an enzyme that catalyses the two-electron reduction of quinone compounds (Ernster, 1987) . Total 4NQO reductase activity can be readily measured in crude cell-extract preparations (Sugimura et al., 1966; Tsuda et al., 1984) . 4HAQO is in turn esterified to acyl-4HAQO, an ultimate carcinogen that reacts at the N2 and the C8 positions of guanosine and at the N6 position of adenosine (Tada & Tada, 1975; Galiegue-Zouitina et al., 1985) . In repair-competent human cells, 4NQO-induced DNA lesions are operated on by both the nucleotide and base modes of excision repair (Regan & Setlow, 1974; Hanawalt et al., 1979) .
To explore the basis of the unusual carcinogen-resistance phenotype displayed by fibroblast strains from available informative members of the cancer-prone family under study, we have also compared these strains with normal controls with respect to: (i) Cytotoxicity assay Cell killing in response to carcinogen treatment was assessed as the loss of colony-forming ability (CFA) using the feeder layer technique detailed previously (Mirzayans et al., 1989a (Mirzayans et al., , 1992 . In brief, late logarithmic cultures were plated at appropriate densities into 100-mm dishes (102 to I04 per dish) and exposed to UV or chemical agents as described above. Alternatively, the cells were harvested by trypsinisation and suspended in ice-cold growth medium, treated with y rays, and then plated out at cloning densities into 100-mm dishes. Gamma ray-inactivated (50 Gy) feeder cells of the same strain were added to all dishes so as to achieve a total density of 5 x 104/dish. Cultures were incubated, with weekly medium changes, for 14-21 days, after which they were fixed and stained with crystal violet, and the number of macroscopic colonies of 100 or more cells was scored. (Waters, 1984) , the slides were dipped in liquified Kodak NTB-2 nuclear track emulsion, dried and exposed (4°C) for 10 days. Finally, the slides were developed and after cell staining with the Giemsa's solution, the number of silver grains above the nuclei of non-S-phase cells was scored. Mirzayans et al., 1988b ).
Measurement of 4NQO-reductase activity Levels of 4NQO-reductase activity in fibroblast strains were measured by the standard cell-free assay system in which NADH is used as the electron donor (Sugimura et al., 1966; Tsuda et al., 1984) , as detailed elsewhere (Mirzayans et al., 1989b (Regan & Setlow, 1974; Mirzayans et al., 1985) . Consequently, the incidence of these immediate alkali-labile modifications has been taken as an index for accurate measurement of variations in 4NQO genotoxic dosimetry among different strains (Mirzayans & Waters, 1981; Edwards et al., 1987; Mirzayans et al., 1988b; 1989a) . These alkali-labile lesions constitute -20% of the total damage induced in cellular DNA by 4NQO (Regan & Setlow, 1974; Waters et al., 1977; Brown et al., 1979; Mirzayans & Waters, 1981) . The remaining 80% of the 4NQO-DNA adducts, which are alkali-stable, are removed by a long-patch excision repair pathway in normal human cells and are thus responsible for much of the unscheduled DNA synthesis (UDS) elicited by this chemical (Regan & Setlow, 1974; Waters et al., 1977; Brown et al., 1979; Mirzayans & Waters, 1981) . As shown in Table III , upon exposure to a given concentration of 4NQO, both the amounts of DNA alkali-labile sites induced initially and the levels of UDS arising in the first 2 h after drug treatment were lower in 4NQO-resistant than in normal fibroblasts. Paterson et al., 1984b Paterson et al., , 1986 Paterson et al., , 1989 Rates of intracellular accumulation of 4NQO To assess the capacity of fibroblast strains to accumulate the drug, cultures were incubated with tritiated 4NQO for various times, whereupon they were lysed and the amounts of radioactivity in the lysates determined. The outcome of a typical time-course experiment conducted on GM38 and 3437T cells is shown in Figure 2 and the results of multiple experiments in which cultures were incubated with the drug (1 pM) for 20 min are averaged in Table III . The levels of radioactive material in GM38 and 3437T cell lysates increased initially in a time-dependent manner and reached a plateau within -10 min of incubation with the radiolabelled compound (Figure 2 ). The levels of radioactivity in cell lysates of all five 4NQO-resistant strains were significantly lower than that found in lysates of normal fibroblasts ( Figure  2 ; Table III retention for GM38 and 3437T cells is presented in Figure 3 . It is evident that 3437T cells accumulated substantially lower amounts of drug over a wide range of treatment concentrations, indicating that the differences in drug accumulation between the two strains is maintained even after supralethal (e.g. 4 pM) exposures.
4NQO-reductase activity in cell sonicates
Rates of NADH oxidation by sonicates of normal and 4NQO-resistant fibroblast strains are presented in Table III . Oxidation of NADH, which parallels the conversion of 4NQO to 4HAQO under the reaction conditions used (Tsuda et al., 1984) , occurred at comparable rates in sonicates of 3703T, 3704T and normal strains (19-21 nmol NADH oxidised/mg protein/min), whereas sonicates of 3437T, and 3701T and 3702T displayed deficient capacities to catalise this reaction (8-12 nmol NADH oxidised/mg protein/min).
Discussion
This study demonstrated that skin fibroblast strains derived from five members of a polyposis/sarcoma family (Figure 1 ; Table I ) exhibit abnormal resistance to reproductive inactivation by 4NQO (Table II) , a partially UV-mimetic and radiomimetic carcinogen (Regan & Setlow, 1974; Hanawalt et al., 1979; Smith & Paterson, 1980) . This unusual cytotoxic response for noncancerous cell types correlated with the introduction of an abnormally low amount of genomic DNA damage on exposure to a given concentration of 4NQO, as a result of decreased accumulation of the chemical in resistant compared to normal fibroblasts (Table III) . In addition, sonicates of cells from two family members who had developed malignancies [i.e. strains 3437T and 3701T (Table I) ] and a member in the cancer-prone lineage [strain 3702T (Figure 1) ] exhibited a reduced capacity to bioactivate 4NQO to a proximate carcinogen (Table III) . As shown in Table II , the 4NQO-resistant cells were inactivated at normal rates by 254 nm UV light, 'Co radiation or the alkylating agent MNU, signifying that the DNA damage processing machinery, including the nucleotide and base modes of the excisionrepair process, functions normally in the drug-resistant cells. We reported previously (Mirzayans et al., 1988b; Mirzayans & Paterson, 1991) that fibroblasts derived from subjects with the radiosensitive disorder ataxia-telangiectasia (A-T; complementation group A) are hypersensitive to killing by 4NQO and contain increased amounts of 4NQO-reductase activity. These same 4NQO-sensitive cells (e.g. strain AT3BI), however, were found to accumulate radiolabelled 4NQO at normal rates (Mirzayans et al., 1988b) . In contrast to that observed with A-T strains, we have demonstrated here that the 4NQO-resistant strains 3703T and 3704T perform 4NQO bioreduction normally but accumulate radiolabelled 4NQO to a reduced extent (Table III) . These results imply that the rate of 4NQO retention in human fibroblasts is independent of cellular capacity to convert the parent compound to 4HAQO. Further studies are required to identify the various metabolic pathways and other factors that govern the accumulation of 4NQO in human cells, one or more of which may be aberrant in the 4NQO-resistant strains reported here.
In another earlier study (Marshall et al., 1991a) , strains 3437T, 3701T and 3702T were found to be more resistant to mitomycin C (MMC)-induced cell killing than two strains from unrelated normal donors. One of these MMC-resistant strains (3437T) showed normal colony-forming ability on exposure to the cross-linking agent cis-dichlorodiammine platinum II (Marshall et al., 1989) , implying that the enhanced resistance of these cells to MMC, which is also a cross-linking agent (Fujiwara, 1982) , does not result from unusually rapid processing of DNA cross links. It should be noted that only those 4NQO-resistant strains harbouring reduced 4NQO-reductase activity (i.e. strains 3437T, 3701T and 3702T, but not 3703T or 3704T) also exhibited significant resistance to MMC. This is reminiscent of the results of Akamatsu and coworkers (1983) who reported that cells from certain patients with familial polyposis coli contained increased 4NQO-reductase activity and were hypersensitive to the lethal effects of both 4NQO and MMC. Together, these observations strongly implicate a common enzyme, presumably DT-diaphorase (Tsuda et al., 1984) , in the bioreduction of the two procarcinogens. In accord with this notion, the aerobic reduction of both 4NQO (Tsuda et al., 1984) and MMC (Keyes et al., 1989; Marshall et al., 1991b) has been demonstrated to be inhibited by dicumarol, a potent (although not specific) inhibitor of DT-diaphorase (Ernster, 1967) . In our earlier work the level of DT-diaphorase activity was also determined for the five fibroblast strains in the polyposis/sarcoma family. Enzyme activities of 1820 and 6680 nmol mg protein/min were present in the two normal strains (GM38 and GM3529), whereas the activities in all five strains from the family members were found to be markedly lower than normal, ranging from 400-800 nmol mg protein/min in 3702T, 3703T and 3704T, to negligible levels (-30 nmol mg protein/min) in 3437T and 3701T (Marshall et al., 1991a) . In this communication cell sonicates of these same strains were shown to carry out 4NQO bioreduction at rates which are either comparable to (i.e. in 3703T, 3704T) or 40-60% lower than (i.e. in 3437T, 3701T, 3702T) the rates measured in cell preparations of four normal strains (Table III) . These striking quantitative differences in the residual levels of DTdiaphorase vs 4NQO-reductase present in the same strains lend support to the hypothesis that a significant component of 4NQO-reductase activity residing in human cells is conferred by reductase(s) distinct from DT-diaphorase.
Dermal fibroblasts from patients with the cancer-prone diseases familial polyposis coli (Akamatsu et al., 1983) , A-T (Mirzayans et al., 1988b; Mirzayans & Paterson, 1991) and dysplastic nevus syndrome (Mirzayans et al., 1989b) typically display hypersensitivity to the cytotoxic action of 4NQO and this abnormal cellular response is accompanied by an enhanced capacity to bioreduce 4NQO to an activated derivative. Conversely, strains 3437T, 3701T and 3702T from three members of the cancer-prone family studied here exhibited decreased susceptibility to 4NQO (Table II) and contained reduced 4NQO-reductase activity (Table III) . Factors that govern the expression of DT-diaphorase and other cellular reductases (Tsuda et al., 1984) remain largely unknown. Their identification should not only establish a molecular basis for bioreduction of 4NQO and related compounds in human cells, but may also provide new insight into the nature of the fundamental genetic defects underlying various cancer-prone disorders. In addition, the discovery of other cancer-associated diseases characterised by anomalies in DT-diaphorase activity may lead to an improved understanding of the link between DT-diaphorase up-regulation [e.g., as seen in subjects with familial polyposis coli (Akamatsu et al., 1983) ] and down-regulation [e.g., as seen in the donors of 3437T and 3701T (Table III) ] and the occurrence of specific cancers.
The observation that strain 3703T from a spousal control of the polyposis/sarcoma family displays enhanced resistance to 4NQO cytotoxicity (Table II ) was unexpected. It should also be noted that strain 3704T from a disease-free family member in the cancer-prone lineage exhibits 4NQO-hyperresistance coupled with decreased 4NQO-reductase/DT-diaphorase activity (Tables II and III; Marshall et al., 1991a) . These findings, however, do not rule out the possibility that the propensity to develop cancer among family members and the impaired capacity of their cultured fibroblasts to bioreduce 4NQO are causally related, each a manifestation of the same primary genetic defect segregating in the family. In fact, this association between cellular reductase activity and tumorigenesis has been reported by other groups in diverse experimental systems (reviewed in Marshall et al., 1991a) . Moreover, an increasing body of evidence suggests that the principal defect in A-T may reside in a regulatory gene whose product may govern the expression of multiple homeostatic mechanisms including those controlling the bioreduction of 4NQO and other xenobiotics (Mirzayans et al., 1989a) . Identification of the primary genetic defect underlying cancer proneness in the family studied here may help to elucidate the functional significance of these homeostatic mechanisms.
